STEM CELLS – A BASIS FOR THERAPY IN THE FUTURE
Yosifova A, Toncheva D*
*Corresponding Author: Professor Draga Toncheva, Department of Medical Genetics, Medical University Sofia, 2 Zdrave str, 1431 Sofia, Bulgaria; Tel./Fax: +359-2-952-03-57; E-mail: dragatoncheva@yahoo.com
page: 3

INTRODUCTION

The discovery of mouse embryonic stem (ES) cells in 1981 [1,2] provided the paradigm and much of the technology for the discovery of human embryonic stem cells. Research on ES cells evolved out of work on mouse teratocarcinomas that consist of a remarkable array of somatic tissues juxtaposed together in a disorganized fashion. The origin of such tumors from germ cells in mice provided the concept of a stem cell (the embryonal carcinoma or EC cell) that can give rise to the multiple types of tissue found in tumors [3]. This field of research expanded considerably with the generation of chimaeric mice by blastocyst injection of EC cells [4]. However, these cells contained chromosomal abnormalities and often had a limited capacity to differentiate into multiple tissue types [5]. Since teratocarcinomas can also be induced by grafting blastocysts to ectopic sites, it was reasoned [2], that it might be possible to derive pluripotent cell lines directly from blastocysts rather than from tumors. Evans and Kaufman [1] and Martin [2] independently obtained a cell line with properties of mouse teratocarcinoma stem cells including pluripotency, cell morphology, and the ability to form teratocarcinomas when injected into mice. The first human ES cells were isolated in 1998 from embryos created through in vitro fertilization (IVF) [6].



Number 27
VOL. 27 (2), 2024
Number 27
VOL. 27 (1), 2024
Number 26
Number 26 VOL. 26(2), 2023 All in one
Number 26
VOL. 26(2), 2023
Number 26
VOL. 26, 2023 Supplement
Number 26
VOL. 26(1), 2023
Number 25
VOL. 25(2), 2022
Number 25
VOL. 25 (1), 2022
Number 24
VOL. 24(2), 2021
Number 24
VOL. 24(1), 2021
Number 23
VOL. 23(2), 2020
Number 22
VOL. 22(2), 2019
Number 22
VOL. 22(1), 2019
Number 22
VOL. 22, 2019 Supplement
Number 21
VOL. 21(2), 2018
Number 21
VOL. 21 (1), 2018
Number 21
VOL. 21, 2018 Supplement
Number 20
VOL. 20 (2), 2017
Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006